Stockreport

TScan Therapeutics Decline Means Insider Profits Down To US$54k [Yahoo! Finance]

TScan Therapeutics, Inc.  (TCRX) 
PDF After accounting for the recent loss, the US$167.9k worth of shares they purchased is now worth US$222.0k, suggesting a good return on their investment. Although we do [Read more]